Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2140394 | Lung Cancer | 2016 | 7 Pages |
Abstract
The present study suggests erlotinib to have similar clinical efficacy compared to chemotherapy in patients with pretreated advanced NSCLC and no known molecular targetable alterations.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
P. Neumair, L. Joos, R. Warschkow, A. Dutly, S. Ess, F. Hitz, M. Früh, M. Brutsche, F. Baty, S. Krähenbühl, T. Cerny, M. Joerger,